Hunan Warrant PharmaceuticalLtd Future Growth

Future criteria checks 1/6

Hunan Warrant PharmaceuticalLtd is forecast to grow revenue at 18.1% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	19.5%
Revenue growth rate	18.1%
Future return on equity	n/a
Analyst coverage	Low
Last updated	06 Mar 2024

Recent future growth updates

No updates

Recent updates

Hunan Warrant Pharmaceutical Co.,Ltd (SHSE:688799) Held Back By Insufficient Growth Even After Shares Climb 26%

Mar 04

Earnings and Revenue Growth Forecasts

SHSE:688799 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	1,997	N/A	79	198	1
12/31/2024	1,717	N/A	69	171	1
3/31/2024	1,448	222	86	207	N/A
12/31/2023	1,433	211	109	214	N/A
9/30/2023	1,421	217	118	241	N/A
6/30/2023	1,421	211	115	246	N/A
3/31/2023	1,358	198	77	208	N/A
12/31/2022	1,293	183	24	156	N/A
9/30/2022	1,267	182	-10	112	N/A
6/30/2022	1,219	175	-20	102	N/A
3/31/2022	1,201	161	-27	86	N/A
12/31/2021	1,147	161	23	115	N/A
9/30/2021	1,120	158	88	134	N/A
6/30/2021	1,083	157	66	103	N/A
3/31/2021	1,005	154	80	132	N/A
12/31/2020	951	145	51	105	N/A
12/31/2019	825	116	92	117	N/A
12/31/2018	613	88	29	65	N/A
12/31/2015	256	19	N/A	11	N/A
12/31/2014	247	28	N/A	37	N/A
12/31/2013	194	21	N/A	23	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 688799's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if 688799's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 688799's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688799's revenue (18.1% per year) is forecast to grow faster than the CN market (14.1% per year).

High Growth Revenue: 688799's revenue (18.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 688799's Return on Equity is forecast to be high in 3 years time

Hunan Warrant PharmaceuticalLtd Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Recent updates

Hunan Warrant Pharmaceutical Co.,Ltd, Annual General Meeting, May 15, 2024

First quarter 2024 earnings released: EPS: CN¥0.64 (vs CN¥0.53 in 1Q 2023)

Now 21% undervalued

Hunan Warrant Pharmaceutical Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

Hunan Warrant Pharmaceutical Co.,Ltd (SHSE:688799) Held Back By Insufficient Growth Even After Shares Climb 26%

Full year 2023 earnings released: EPS: CN¥2.25 (vs CN¥1.95 in FY 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 23%

Third quarter 2023 earnings released: EPS: CN¥0.49 (vs CN¥0.43 in 3Q 2022)

Investor sentiment improves as stock rises 23%

Second quarter 2023 earnings released: EPS: CN¥0.67 (vs CN¥0.53 in 2Q 2022)

Now 20% undervalued after recent price drop

Hunan Warrant Pharmaceutical Co.,Ltd to Report First Half, 2023 Results on Aug 28, 2023

First quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥1.92 (vs CN¥2.01 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.24 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.50 in 2Q 2021)

Full year 2021 earnings released: EPS: CN¥2.00 (vs CN¥2.06 in FY 2020)

Investor sentiment deteriorated over the past week

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies